TrimRx's Blog

The hardest question in CKD care isn’t which drug to use; it’s when to start.

Here’s the uncomfortable truth: by the time most people feel something wrong with their kidneys, they’ve already lost half their function.

The treatment landscape for chronic kidney disease has changed more in the last five years than in the previous twenty.

CKD changes the calculus of everyday choices.

CKD is a marathon, not a sprint. The decisions you make in years 1, 5, and 10 of diagnosis compound.

Until 2024, GLP-1 receptor agonists were primarily a glucose and weight drug class.

For decades, kidney patients were told to take it easy. The thinking was that exercise stresses the kidneys and might accelerate damage.

The old renal diet handout was dispiriting. No bananas. No tomatoes. No oranges. No dairy. Half the supermarket crossed off.

Chronic kidney disease quietly affects roughly 37 million American adults, and the CDC estimates about 90% of them don’t know they have it.